Publication | Open Access
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
82
Citations
31
References
2021
Year
NCT04568707.
| Year | Citations | |
|---|---|---|
Page 1
Page 1